BA Health case study to know how our research team helped the client understand the message testing study for cholesterol treatment. This quantitative study enabled the client to face increasing competition from the related generics and new products in Europe. Targeted various medical professionals treating patients with cholesterol across France, Germany, Italy, Netherlands, Spain, and the UK, the study evaluated all existing brand messages, analyzed the messages designed to support new proposition and identified the message option most likely to be prescribed. The outcome revealed whether the majority of the physicians found the client’s brand credible compared to the competition or not. The study insights hence became the base of the client’s new campaign on the “cardiovascular risk spectrum
Study Type Quantitative Research
Geography France, Germany, Italy, Netherlands, Spain, UK
Sample Size n=120
Target Group GPs, Cardiologist, Endocrinologist / Dialectologist